Stay updated with breaking news from Tom Riga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spectrum Pharmaceuticals entered into a five-year debt financing agreement with investment affiliates managed by SLR Capital Partners, LLC (SLR) for a term loan facility of up to $65 million. The Company believes this transaction, combined with Spectrum's existing cash balance, provides sufficient capital to optimize the commercial launch of...
Most FDA panelists expressed doubts about the strength of evidence regarding the benefits of the experimental drug, especially given available therapies.
Spectrum Pharmaceuticals received regulatory approval for its oncology-related infection-reducing therapeutic, bolstering SPPI stock.
First novel Long-Acting GCSF (LA-GCSF) product approved in over 20 yearsROLVEDON™ developed using proprietary LAPSCOVERY™ technology with a differentiated molecular structure and proven safety and efficacy profileCommercial team ready to launch with product available in the fourth quarterBOSTON--(BUSINESS WIRE)--Spe...
SPPI earnings call for the period ending June 30, 2022.